Current and future effects of varicella and herpes zoster vaccination in Germany – Insights from a mathematical model in a country with universal varicella vaccination

References

• Fairley CK, Miller E. Varicella-zoster virus epidemiology–a changing scene? J Infect Dis 1996; 174 Suppl 3:S314-9; PMID:8896538; http://dx.doi.org/10.1093/infdis/174.Supplement_3.S314
   PubMedGoogle Scholar
• Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ open 2014; 4:e004833; PMID:24916088; http://dx.doi.org/10.1136/bmjopen-2014-004833
   PubMed Web of Science ®Google Scholar
• Begründung der STIKO für eine allgemeine Varizellenimpfung. Epidemiologisches Bulletin 2004; 49:421.
   Google Scholar
• Dworkin RH, Portenoy RK. Pain and its persistence in herpes zoster. Pain 1996; 67:241-51; PMID:8951917; http://dx.doi.org/10.1016/0304-3959(96)03122-3
   PubMed Web of Science ®Google Scholar
• Streng A, Grote V, Carr D, Hagemann C, Liese JG. Varicella routine vaccination and the effects on varicella epidemiology - results from the Bavarian Varicella Surveillance Project (BaVariPro), 2006–2011. BMC Infect Dis 2013; 13:303; PMID:23815523; http://dx.doi.org/10.1186/1471-2334-13-303
   PubMed Web of Science ®Google Scholar
• Siedler A, Arndt U. Impact of the routine varicella vaccination programme on varicella epidemiology in Germany. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 2010; 15(13):pii=19530
   Google Scholar
• Hope-Simpson RE. The Nature of Herpes Zoster: A Long-Term Study and a New Hypothesis. Proc Royal Soc Med 1965; 58:9-20; PMID:14267505
   PubMedGoogle Scholar
• Brisson M, Gay NJ, Edmunds WJ, Andrews NJ. Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine 2002; 20:2500-7; PMID:12057605; http://dx.doi.org/10.1016/S0264-410X(02)00180-9
   PubMed Web of Science ®Google Scholar
• Ogunjimi B, Van Damme P, Beutels P. Herpes Zoster Risk Reduction through Exposure to Chickenpox Patients: A Systematic Multidisciplinary Review. PloS one 2013; 8:e66485; PMID:23805224; http://dx.doi.org/10.1371/journal.pone.0066485
   PubMed Web of Science ®Google Scholar
• Brisson M, Edmunds WJ, Gay NJ, Law B, De Serres G. Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiol Infect 2000; 125:651-69; PMID:11218215; http://dx.doi.org/10.1017/S0950268800004714
   PubMed Web of Science ®Google Scholar
• Gidding HF, Brisson M, Macintyre CR, Burgess MA. Modelling the impact of vaccination on the epidemiology of varicella zoster virus in Australia. Aust N Z J Public Health 2005; 29:544-51; PMID:16366065; http://dx.doi.org/10.1111/j.1467-842X.2005.tb00248.x
   PubMed Web of Science ®Google Scholar
• Schuette MC, Hethcote HW. Modeling the effects of varicella vaccination programs on the incidence of chickenpox and shingles. Bull Math Biol 1999; 61:1031-64; PMID:17879870; http://dx.doi.org/10.1006/bulm.1999.0126
   PubMed Web of Science ®Google Scholar
• Coudeville L, Brunot A, Szucs TD, Dervaux B. The economic value of childhood varicella vaccination in France and Germany. Value Health 2005; 8:209-22; PMID:15877593; http://dx.doi.org/10.1111/j.1524-4733.2005.04005.x
   PubMed Web of Science ®Google Scholar
• Brisson M, Melkonyan G, Drolet M, De Serres G, Thibeault R, De Wals P. Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zoster. Vaccine 2010; 28:3385-97; PMID:20199763; http://dx.doi.org/10.1016/j.vaccine.2010.02.079
   PubMed Web of Science ®Google Scholar
• van Hoek AJ, Melegaro A, Zagheni E, Edmunds WJ, Gay N. Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England. Vaccine 2011; 29:2411-20; PMID:21277405; http://dx.doi.org/10.1016/j.vaccine.2011.01.037
   PubMed Web of Science ®Google Scholar
• van Hoek AJ, Melegaro A, Gay N, Bilcke J, Edmunds WJ. The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom. Vaccine 2012; 30:1225-34; PMID:22119592; http://dx.doi.org/10.1016/j.vaccine.2011.11.026
   PubMed Web of Science ®Google Scholar
• Bilcke J, Ogunjimi B, Hulstaert F, Van Damme P, Hens N, Beutels P. Estimating the age-specific duration of herpes zoster vaccine protection: a matter of model choice? Vaccine 2012; 30:2795-800; PMID:21964056; http://dx.doi.org/10.1016/j.vaccine.2011.09.079
   PubMed Web of Science ®Google Scholar
• Ogunjimi B, Willem L, Beutels P, Hens N. Integrating between-host transmission and within-host immunity to analyze the impact of varicella vaccination on zoster. eLife 2015; 4:e07116; PMID:26259874; http://dx.doi.org/10.7554/eLife.07116
   PubMed Web of Science ®Google Scholar
• Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS medicine 2008; 5:e74; PMID:18366252; http://dx.doi.org/10.1371/journal.pmed.0050074
   PubMed Web of Science ®Google Scholar
• Karhunen M, Leino T, Salo H, Davidkin I, Kilpi T, Auranen K. Modelling the impact of varicella vaccination on varicella and zoster. Epidemiol Infect 2010; 138:469-81; PMID:19796447; http://dx.doi.org/10.1017/S0950268809990768
   PubMed Web of Science ®Google Scholar
• Guzzetta G, Poletti P, Del Fava E, Ajelli M, Scalia Tomba GP, Merler S, et al. Hope-Simpson's progressive immunity hypothesis as a possible explanation for herpes zoster incidence data. Am J Epidemiol 2013; 177:1134-42; PMID:23548754; http://dx.doi.org/10.1093/aje/kws370
   PubMed Web of Science ®Google Scholar
• Ultsch B, Koster I, Reinhold T, Siedler A, Krause G, Icks A, et al. Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany. Eur J Health Econ 2012; 14(6):1015-26; PMID:23271349
   PubMed Web of Science ®Google Scholar
• Poletti P, Melegaro A, Ajelli M, Del Fava E, Guzzetta G, Faustini L, et al. Perspectives on the impact of varicella immunization on herpes zoster. A model-based evaluation from three European countries. PloS one 2013; 8:e60732; PMID:23613740; http://dx.doi.org/10.1371/journal.pone.0060732
   PubMed Web of Science ®Google Scholar
• Weinmann S, Chun C, Schmid DS, Roberts M, Vandermeer M, Riedlinger K, et al. Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005–2009. J Infect Dis 2013; 208:1859-68; PMID:23922376; http://dx.doi.org/10.1093/infdis/jit405
   PubMed Web of Science ®Google Scholar
• Baxter R, Ray P, Tran TN, Black S, Shinefield HR, Coplan PM, et al. Long-term effectiveness of varicella vaccine: a 14-Year, prospective cohort study. Pediatrics 2013; 131:e1389-96; PMID:23545380; http://dx.doi.org/10.1542/peds.2012-3303
   PubMed Web of Science ®Google Scholar
• Hardy I, Gershon AA, Steinberg SP, LaRussa P. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group. N Engl J Med 1991; 325:1545-50; PMID:1658650; http://dx.doi.org/10.1056/NEJM199111283252204
   PubMed Web of Science ®Google Scholar
• Stein M, Cohen R, Bromberg M, Tasher D, Shohat T, Somekh E. Herpes zoster in a partially vaccinated pediatric population in central Israel. Pediatric Infect Dis J 2012; 31:906-9; PMID:22627868; http://dx.doi.org/10.1097/INF.0b013e31825d33f9
   PubMed Web of Science ®Google Scholar
• Goldman GS. Cost-benefit analysis of universal varicella vaccination in the U.S. taking into account the closely related herpes-zoster epidemiology. Vaccine 2005; 23:3349-55; PMID:15837242; http://dx.doi.org/10.1016/j.vaccine.2003.10.042
   PubMed Web of Science ®Google Scholar
• Civen R, Chaves SS, Jumaan A, Wu H, Mascola L, Gargiullo P, et al. The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination. Pediatric Infect Dis J 2009; 28:954-9; PMID:19536039; http://dx.doi.org/10.1097/INF.0b013e3181a90b16
   PubMed Web of Science ®Google Scholar
• van Hoek AJ, Gay N, Melegaro A, Opstelten W, Edmunds WJ. Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales. Vaccine 2009; 27:1454-67; PMID:19135492; http://dx.doi.org/10.1016/j.vaccine.2008.12.024
   PubMed Web of Science ®Google Scholar
• Ultsch B, Weidemann F, Reinhold T, Siedler A, Krause G, Wichmann O. Health economic evaluation of vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia in Germany. BMC Health Services Res 2013; 13:359; PMID:24070414; http://dx.doi.org/10.1186/1472-6963-13-359
   PubMed Web of Science ®Google Scholar
• de Boer PT, Pouwels KB, Cox JM, Hak E, Wilschut JC, Postma MJ. Cost-effectiveness of vaccination of the elderly against herpes zoster in The Netherlands. Vaccine 2013; 31:1276-83; PMID:23306360; http://dx.doi.org/10.1016/j.vaccine.2012.12.067
   PubMed Web of Science ®Google Scholar
• Prymula R, Bergsaker MR, Esposito S, Gothefors L, Man S, Snegova N, et al. Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trial. Lancet 2014; 383:1313-24; PMID:24485548; http://dx.doi.org/10.1016/S0140-6736(12)61461-5
   PubMed Web of Science ®Google Scholar
• Shapiro ED, Vazquez M, Esposito D, Holabird N, Steinberg SP, Dziura J, et al. Effectiveness of 2 doses of varicella vaccine in children. J Infect Dis 2011; 203:312-5; PMID:21208922; http://dx.doi.org/10.1093/infdis/jiq052
   PubMed Web of Science ®Google Scholar
• Kuter B, Matthews H, Shinefield H, Black S, Dennehy P, Watson B, et al. Ten year follow-up of healthy children who received one or two injections of varicella vaccine. Pediatric Infect Dis J 2004; 23:132-7; PMID:14872179; http://dx.doi.org/10.1097/01.inf.0000109287.97518.67
   PubMed Web of Science ®Google Scholar
• Parker AA, Reynolds MA, Leung J, Anderson M, Rey A, Ortega-Sanchez IR, et al. Challenges to implementing second-dose varicella vaccination during an outbreak in the absence of a routine 2-dose vaccination requirement–Maine, 2006. J Infect Dis 2008; 197 Suppl 2:S101-7; PMID:18419381; http://dx.doi.org/10.1086/522134
   PubMedGoogle Scholar
• Tugwell BD, Lee LE, Gillette H, Lorber EM, Hedberg K, Cieslak PR. Chickenpox outbreak in a highly vaccinated school population. Pediatrics 2004; 113:455-9; PMID:14993534; http://dx.doi.org/10.1542/peds.113.3.455
   PubMed Web of Science ®Google Scholar
• Marziano V, Poletti P, Guzzetta G, Ajelli M, Manfredi P, Merler S. The impact of demographic changes on the epidemiology of herpes zoster: Spain as a case study. Proc Biol Sci 2015; 282:20142509; PMID:25761709; http://dx.doi.org/10.1098/rspb.2014.2509
   PubMed Web of Science ®Google Scholar
• Horn J, Damm O, Kretzschmar M, Siedler A, Wichmann O, Ultsch B, et al. Mathematische Modellierung der Auswirkungen der Varizellen-Impfung auf die Inzidenz von Herpes Zoster in Deutschland. Jahrestagung DGEpi 2013. Leipzig, 26. - 29. Sep 2013, 2013; 232:193.
   Google Scholar
• Lal H, Cunningham AL, Godeaux O, Chlibek R, Diez-Domingo J, Hwang SJ, et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med 2015; 372:2087-96; PMID:25916341; http://dx.doi.org/10.1056/NEJMoa1501184
   PubMed Web of Science ®Google Scholar
• Wutzler P, Farber I, Wagenpfeil S, Bisanz H, Tischer A. Seroprevalence of varicella-zoster virus in the German population. Vaccine 2001; 20:121-4; PMID:11567755; http://dx.doi.org/10.1016/S0264-410X(01)00276-6
   PubMed Web of Science ®Google Scholar
• Wutzler P, Neiss A, Banz K, Goertz A, Bisanz H. Can varicella be eliminated by vaccination? Potential clinical and economic effects of universal childhood varicella immunisation in Germany. Med Microbiol Immunol 2002; 191:89-96; PMID:12410347; http://dx.doi.org/10.1007/s00430-002-0123-4
   PubMed Web of Science ®Google Scholar
• Zur Seroprävalenz gegen Varizella-Zoster-Virus und zur Verlässlichkeit anamnestischer Angaben. Epidemiologisches Bulletin 2003; 43:347
   Google Scholar
• Ultsch B, Siedler A, Rieck T, Reinhold T, Krause G, Wichmann O. Herpes zoster in Germany: quantifying the burden of disease. BMC Infect Dis 2011; 11:173; PMID:21679419; http://dx.doi.org/10.1186/1471-2334-11-173
   PubMed Web of Science ®Google Scholar
• Schiffner-Rohe J, Jow S, Lilie HM, Koster I, Schubert I. [Herpes zoster in Germany. A retrospective analyse of SHL data]. MMW Fortschritte der Medizin 2010; 151 Suppl 4:193-7; PMID:21595148
   PubMedGoogle Scholar
• Statistisches Bundesamt. GENESIS Online-Datenbank. 2015.
   Google Scholar
• Reuss AM, Feig M, Kappelmayer L, Siedler A, Eckmanns T, Poggensee G. Varicella vaccination coverage of children under two years of age in Germany. BMC Public Health 2010; 10:502; PMID:20723217; http://dx.doi.org/10.1186/1471-2458-10-502
   PubMed Web of Science ®Google Scholar
• Rieck T, Feig M, Eckmanns T, Benzler J, Siedler A, Wichmann O. Vaccination coverage among children in Germany estimated by analysis of health insurance claims data. Hum Vaccin Immunother 2014; 10:476-84; PMID:24192604; http://dx.doi.org/10.4161/hv.26986
   PubMed Web of Science ®Google Scholar
• Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352:2271-84; PMID:15930418; http://dx.doi.org/10.1056/NEJMoa051016
   PubMed Web of Science ®Google Scholar
• Garnett GP, Grenfell BT. The epidemiology of varicella-zoster virus infections: the influence of varicella on the prevalence of herpes zoster. Epidemiol Infect 1992; 108:513-28; PMID:1318219; http://dx.doi.org/10.1017/S0950268800050019
   PubMed Web of Science ®Google Scholar
• Bayer O, Heininger U, Heiligensetzer C, von Kries R. Metaanalysis of vaccine effectiveness in varicella outbreaks. Vaccine 2007; 25:6655-60; PMID:17706845; http://dx.doi.org/10.1016/j.vaccine.2007.07.010
   PubMed Web of Science ®Google Scholar
• Seward JF, Marin M, Vazquez M. Varicella vaccine effectiveness in the US vaccination program: a review. J Infect Dis 2008; 197 Suppl 2:S82-9; PMID:18419415; http://dx.doi.org/10.1086/522145
   PubMed Web of Science ®Google Scholar
• Izurieta HS, Strebel PM, Blake PA. Postlicensure effectiveness of varicella vaccine during an outbreak in a child care center. JAMA 1997; 278:1495-9; http://dx.doi.org/10.1001/jama.1997.03550180045035
   PubMed Web of Science ®Google Scholar
• Oxman MN, Levin MJ, Shingles Prevention Study G. Vaccination against Herpes Zoster and Postherpetic Neuralgia. J Infect Dis 2008; 197 Suppl 2:S228-36; PMID:18419402; http://dx.doi.org/10.1086/522159
   PubMed Web of Science ®Google Scholar
• Schmader KE, Levin MJ, Gnann JW, Jr., McNeil SA, Vesikari T, Betts RF, et al. Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50–59 years. Clin Infect Dis 2012; 54:922-8; PMID:22291101; http://dx.doi.org/10.1093/cid/cir970
   PubMed Web of Science ®Google Scholar